Market Overview

UPDATE: Bank of America Downgrades Constellation Brands to Neutral; Crown Transaction in Jeopardy

Share:
Related STZ
U.S. Adults Trade BUD For Bud: How Legal Weed Is Hurting The Beer Industry
ArcView CEO Troy Dayton On Cannabis Going Mainstream, Entering Major Capital Markets

Bank of America downgraded Constellation Brands (NYSE: STZ) from Buy to Neutral and lowered the price target from $42.00 to $33.00.

Bank of America said, "It is unclear to us whether the DOJ will prevail in its case against ABI or if the two sides can still reach a settlement; however, it does appear that the final resolution has been delayed and could take as long as a year. As a result, we think the stock could remain range bound as the issue is sorted out in the courts. We are lowering our FY14E EPS from $2.77 to $2.16 to reflect our expectation for delayed timing of the Crown transaction. Our $33 PO implies 15.2x our new estimate, essentially maintaining the target multiple but applying to a lower earnings base."

Constellation Brands closed at $32.36 on Thursday.

Latest Ratings for STZ

DateFirmActionFromTo
Nov 2016Bank of AmericaDowngradesNeutralUnderperform
Oct 2016SunTrust Robinson HumphreyMaintainsBuy
Oct 2016UBSMaintainsNeutral

View More Analyst Ratings for STZ
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Downgrades Analyst Ratings

 

Related Articles (STZ)

View Comments and Join the Discussion!